Serum level of expressed in renal carcinoma (ERC)/mesothelin in rats with mesothelial proliferative lesions induced by multi-wall carbon nanotube (MWCNT)

Journal of Toxicological Sciences

Volumn 35, Issue 2, 2010, Pages 265-270

  Sakamoto, Yoshimitsu ^a   Nakae, Dai ^a,b   Hagiwara, Yoshiaki ^c,d   Satoh, Kanako ^a   Ohashi, Norio ^a   Fukamachi, Katsumi ^e   Tsuda, Hiroyuki ^e   Hirose, Akihiko ^f   Nishimura, Tetsuji ^f   Hino, Okio ^c   Ogata, Akio ^a  

^a TOKYO METROPOLITAN INSTITUTE OF PUBLIC HEALTH   (Japan)

^b TOKYO UNIVERSITY OF AGRICULTURE   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Immuno Biological Laboratories Co Ltd   (Japan)

^e NAGOYA CITY UNIVERSITY   (Japan)

^f NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Mesothelial proliferative lesions; MWCNT; Rat; Serum mesothelin

Indexed keywords

BIOLOGICAL MARKER; MESOTHELIN; MULTI WALLED NANOTUBE;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MALE; MESOTHELIOMA; MESOTHELIUM; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANIMALIA; RATTUS;

EID: 77951661397     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.35.265     Document Type: Article

References (16)

1. Chang, K. and Pastan, I. (1996): Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. PNAS USA, 93, 136-140. (Pubitemid 26041483)
2. Fukamachi, K., Tanaka, H., Hagiwara, Y., Ohara, H., Joh, T., Iigo, M., Alexander, D.B., Xu, J., Long, N., Takigahira, M., Yanagihara, K., Hino, O., Saito, I. and Tsuda, H. (2009): An animal model of preclinical diagnosis of pancreatic ductal carcinomas. Biochem. Biophys. Res. Commun., 390, 636-641.
3. Hagiwara, Y., Hamada, Y., Kuwahara, M., Maeda, M., Segawa, T., Ishikawa, K. and Hino, O. (2008): Establishment of a novel specific ELISA system for rat N- and C-ERC/mesothelin. Rat ERC/ mesothelin in the body fluids of mice bearing mesothelioma. Cancer Sci., 99, 666-670.
4. Hassan, R., Remaley, A.T., Sampson, M.L. Zhang, J., Cox, D.D., Pingpank, J., Alexander, R., Willingham, M., Pastan, I. and Onda, M. (2006): Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer. Clin. Cancer Res., 12, 447-453.
5. Hino, O., Kobayashi, E., Nishizawa, M., Kubo, Y., Kobayashi, T., Hirayama, Y., Takai, S., Kikuchi, Y., Tsuchiya, H., Orimoto, K., Kajino, K., Takahata, T. and Hitani, H. (1995): Renal carcinogenesis in the Eker rat. J. Cancer Res. Clin. Oncol., 121, 602-605.
6. Hino, O. (2004): Multistep renal carcinogenesis in the Eker (Tsc2 gene mutant) rat model. Curr. Mol. Med., 4, 807-811.
7. Hino, O., Shiomi, K. and Maeda, M. (2007): Diagnostic biomarker of asbestos-related mesothelioma: example of translational research. Cancer Sci., 98, 1147-1151.
8. Maeda, M. and Hino, O. (2006): Molecular tumor markers for asbestos-related mesothelioma: serum diagnostic markers. Pathol. Int., 56, 649-654.
9. Ordóñez, N.G. (2003): Value of mesothelin immunostaining in the diagnosis of mesothelioma. Mod. Pathol., 16, 192-197.
10. Nakaishi, M., Kajino, K., Ikesue, M., Hagiwara, Y., Kuwahara, M., Mitani, H., Horikoshi-Sakuraba, Y., Segawa, T., Kon, S., Maeda, M., Wang, T., Abe, M., Yokoyama, M. and Hino, O. (2007): Establishment of the enzyme-linked immunosorbent assay system to detect the amino terminal secretary form of rat Erc/Mesothelin. Cancer Sci., 98, 659-664. (Pubitemid 46563441)
11. Sakamoto, Y., Nakae, D., Fukumori, N., Tayama, K., Maekawa, A., Imai, K., Hirose, A., Nishimura, T., Ohashi, N. and Ogata, A. (2009): Induction of mesothelioma by a single intrascrotal administration of multi-wall carbon nanotube in intact male Fischer 344 rats. J. Toxicol. Sci., 34, 65-76.
12. Shiomi, K., Miyamoto, H., Segawa, T., Hagiwara, Y., Ota, A., Maeda, M., Takahashi, K., Masuda, K., Sakao, Y. and Hino, O. (2006): Novel ELISA system for detection of N-ERC/mesothelin in the sera of mesothelioma patients. Cancer Sci., 97, 928-932. (Pubitemid 44151275)
13. Shiomi, K., Hagiwara, Y., Sonoue, K., Segawa, T., Miyashita, K., Maeda, M., Izumi, H., Masuda, K., Hirabayashi, M., Moroboshi, T., Yoshiyama, T., Ishida, A., Natori, Y., Inoue, A., Kobayashi, M., Sakao, Y., Miyamoto, H., Takahashi, K. and Hino, O. (2008): Sensitive and specific new enzyme-linked immunosorbent assay for N-ERC/mesothelin increases its potential as a useful serum tumor marker for mesothelioma. Clin. Cancer Res., 14, 1431-1437.
14. Tajima, K., Hirama, M., Shiomi, K., Ishiwata, T., Yoshioka, M., Iwase, A., Iwakami, S., Yamazaki, M., Toba, M., Tobino, K., Sugano, K., Ichikawa, M., Hagiwara, Y., Takahashi, K. and Hino, O. (2008): ERC/mesothelin as a marker for chemotherapeutic response in patients with mesothelioma. Anticancer Res., 28, 3933-3936.
15. Yamaguchi, N., Hattori, K., Oheda, M., Kojima, T., Imai, N. and Ochi, N. (1994): A novel cytokine exhibiting megakaryocyte potentiating activity from a human pancreatic tumor-cell line HPC-Y5. J. Biol. Chem., 269, 805-808.
16. Yamashita, Y., Yokoyama, M., Kobayashi, E., Takai, S. and Hino, O. (2000): Mapping and determination of the cDNA sequence of the Erc gene preferentially expressed in renal cell carcinoma in the Tsc2 gene mutant (Eker) rat model. Biochem. Biophys. Res. Commun., 275, 134-140.